P2RX7 and neoplasm: Indeed, studies using tumor cell lines and preclinical mouse models in melanoma [33,34], non-melanoma skin cancers [35], intestinal carcinomas [36] and breast cancer [37] have shown that activation of P2RX7 reduced cell proliferation by inducing cell death.